Investigator-Initiated Phase 2 study is being conducted at Northwestern University in cooperation with Moleculin. Trial combines WP1066 and radiation, which demonstrated both significant therapeutic response and immune "memory" in glioblastoma animal models
Under terms of the agreement, AbbVie and Gilgamesh Pharmaceuticals have agreed to research and develop a portfolio of next-generation therapeutics for psychiatric disorders.
Investigator-Initiated Phase 2 study is being conducted at Northwestern University in cooperation with Moleculin. Trial combines WP1066 and radiation, which demonstrated both significant therapeutic response and immune "memory" in glioblastoma animal models
USMI & JCRI have developed a Humidified Electrical Reactive Oxygen System (The Canady Helios™ Cold Plasma HERO™ System) which generates an ionized cold plasma mixed with the Air/O2 from oxygen sources such as hospital ventilators, CPAPs (Continuous Positive Airway Pressure), BIPAPs (Bilevel Positive Airway Pressure) or O2 face masks.
Fast and accurate testing labs at international terminals offer a new solution, as airports continue to be a focal point in the global spread of COVID-19.
Medtecs notes the world has been hit again by the resurgence in confirmed COVID-19 cases brought about by the highly contagious Delta variant. The number of cases worldwide has surpassed the 200 million mark, with a large number of children now being included in the daily tally, straining pediatric resources and healthcare systems.
According to medical experts, children under the age of 12 who are not yet eligible for vaccination are at high risk for infection by the Delta variant....
This integration unlocks new antibody discovery workflows like performing structural analysis of proteins of interest and annotating important liability characteristics to select antibody candidates with good developability properties.
“Today’s announcement is a significant milestone for Cerus as we enter the Canadian market. We are proud to partner with Canadian Blood Services to introduce pathogen inactivated platelets in Canada,” said Christian Boutemy, Cerus’ vice president, commercial operations EMEA, who is also responsible for Canada.
Thermo Fischer Scientific Heracell Vios CR CO2 Incubator expands the Thermo Scientific Cell Therapy Systems (CTS) Series laboratory equipment portfolio with a solution specifically designed for use in GMP environments.
By using this website you agree to accept Medical Device News Magazine Privacy Policy
